{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:17:04Z","timestamp":1792891024604,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010699","name":"Monash University Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010699","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.arr.2026.103058","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T15:46:52Z","timestamp":1770565612000},"page":"103058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Blood-based biomarkers for Alzheimer's disease: Advances in early detection and monitoring of age-related neurodegeneration"],"prefix":"10.1016","volume":"117","author":[{"given":"Wenting","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9213-7116","authenticated-orcid":false,"given":"Paul Chi-Lui","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2026.103058_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-019-0562-4","article-title":"CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia","volume":"12","author":"Abu-Rumeileh","year":"2020","journal-title":"Alz Res Ther."},{"key":"10.1016\/j.arr.2026.103058_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45050-1","article-title":"Theoretical analysis of immunochromatographic assay and consideration of its operating parameters for efficient designing of high-sensitivity cardiac troponin I (hs-cTnI) detection","volume":"13","author":"Agarwal","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2026.103058_bib3","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3233\/JAD-215093","article-title":"Novel Ultrasensitive Detection Technologies for the Identification of Early and Minimally Invasive Alzheimer\u2019s Disease Blood Biomarkers","volume":"86","author":"\u00c1lvarez-S\u00e1nchez","year":"2022","journal-title":"JAD"},{"key":"10.1016\/j.arr.2026.103058_bib4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s43587-025-00810-8","article-title":"Soluble cerebral A\u03b2 protofibrils link A\u03b2 plaque pathology to changes in CSF A\u03b242\/A\u03b240 ratios, neurofilament light and tau in Alzheimer\u2019s disease model mice","volume":"5","author":"Andersson","year":"2025","journal-title":"Nat. Aging"},{"key":"10.1016\/j.arr.2026.103058_bib5","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.38544","article-title":"Neuroimaging in Alzheimer\u2019s disease for early diagnosis: a comprehensive review","author":"Aramadaka","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.arr.2026.103058_bib6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103058_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/jpm10030114","article-title":"Biomarkers for Alzheimer\u2019s disease early diagnosis","volume":"10","author":"Aus\u00f3","year":"2020","journal-title":"JPM"},{"key":"10.1016\/j.arr.2026.103058_bib8","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20199356","article-title":"Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer\u2019s disease","volume":"16","author":"Bader","year":"2020","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.arr.2026.103058_bib9","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200861","article-title":"Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer\u2019s disease","volume":"217","author":"Barth\u00e9lemy","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.arr.2026.103058_bib10","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41591-024-02869-z","article-title":"Highly accurate blood test for Alzheimer\u2019s disease is similar or superior to clinical cerebrospinal fluid tests","volume":"30","author":"Barth\u00e9lemy","year":"2024","journal-title":"Nat. Med"},{"key":"10.1016\/j.arr.2026.103058_bib11","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/s00259-024-07016-x","article-title":"Subcortical tau deposition and plasma glial fibrillary acidic protein as predictors of cognitive decline in mild cognitive impairment and Alzheimer\u2019s disease","volume":"52","author":"Chang","year":"2025","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103058_bib12","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1002\/alz.12879","article-title":"Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer\u2019s disease: Associations with A\u03b2-PET, neurodegeneration, and cognition","volume":"19","author":"Chatterjee","year":"2023","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.arr.2026.103058_bib13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/alz.12724","article-title":"Plasma A\u03b242\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer\u2019s disease continuum: A cross-sectional and longitudinal study in the AIBL cohort","volume":"19","author":"Chatterjee","year":"2023","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.arr.2026.103058_bib14","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1002\/mas.21788","article-title":"Targeted protein quantitation in human body fluids by mass spectrometry","volume":"42","author":"Chen","year":"2023","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.arr.2026.103058_bib15","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3233\/JAD-231162","article-title":"Combining Blood-Based Biomarkers and Structural MRI Measurements to Distinguish Persons with and without Significant Amyloid Plaques","volume":"98","author":"Chen","year":"2024","journal-title":"JAD"},{"key":"10.1016\/j.arr.2026.103058_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101446","article-title":"Diagnostic accuracy of blood biomarkers for Alzheimer\u2019s disease and amnestic mild cognitive impairment: A meta-analysis","volume":"71","author":"Chen","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103058_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13024-023-00647-y","article-title":"Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer\u2019s disease with multi-modal PET and plasma GFAP","volume":"18","author":"Chiotis","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2026.103058_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae247","article-title":"Multi-peptide characterization of plasma neurofilament light chain in preclinical and mild Alzheimer\u2019s disease","volume":"6","author":"Coulton","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.arr.2026.103058_bib19","author":"Daniels","year":"2024","journal-title":"15 Years Longitud. Genet. Clin. Cogn. Imaging Biochem. Meas. DIAN"},{"key":"10.1016\/j.arr.2026.103058_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neurol.2022.09.003","article-title":"Overview of the blood biomarkers in Alzheimer\u2019s disease: Promises and challenges","volume":"179","author":"Delaby","year":"2023","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.arr.2026.103058_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40035-021-00234-5","article-title":"Ultrasensitive assays for detection of plasma tau and phosphorylated tau 181 in Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"10","author":"Ding","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2026.103058_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/alzrt186","article-title":"Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer\u2019s disease","volume":"5","author":"Donovan","year":"2013","journal-title":"Alz Res Ther."},{"key":"10.1016\/j.arr.2026.103058_bib23","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.1017\/S0033291723001952","article-title":"Plasma biomarkers of neurodegeneration in mild cognitive impairment with Lewy bodies","volume":"53","author":"Hamilton","year":"2023","journal-title":"Psychol. Med."},{"key":"10.1016\/j.arr.2026.103058_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021643","article-title":"Metabolomics in Early Alzheimer\u2019s Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics","volume":"6","author":"Han","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.arr.2026.103058_bib25","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","article-title":"Blood biomarkers for Alzheimer\u2019s disease in clinical practice and trials","volume":"3","author":"Hansson","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.arr.2026.103058_bib26","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1038\/s41467-024-52937-8","article-title":"Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer\u2019s disease","volume":"15","author":"Hofmann","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103058_bib27","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/alz.13697","article-title":"Biomarkers of Alzheimer\u2019s disease and neurodegeneration in dried blood spots\u2014A new collection method for remote settings","volume":"20","author":"Huber","year":"2024","journal-title":"Alzheimer\u2019S. amp Dement."},{"key":"10.1016\/j.arr.2026.103058_bib28","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11095-021-03036-6","article-title":"Dried Blood Spot Technique Applied in Therapeutic Drug Monitoring of Anticancer Drugs: a Review on Conversion Methods to Correlate Plasma and Dried Blood Spot Concentrations","volume":"38","author":"Iacuzzi","year":"2021","journal-title":"Pharm. Res"},{"key":"10.1016\/j.arr.2026.103058_bib29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat. Med"},{"key":"10.1016\/j.arr.2026.103058_bib30","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jamaneurol.2024.2619","article-title":"Plasma Phosphorylated Tau 217 and A\u03b242\/40 to Predict Early Brain A\u03b2 Accumulation in People Without Cognitive Impairment","volume":"81","author":"Janelidze","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103058_bib31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12916-021-02142-x","article-title":"Prediction of P-tau\/A\u03b242 in the cerebrospinal fluid with blood microRNAs in Alzheimer\u2019s disease","volume":"19","author":"Jia","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/j.arr.2026.103058_bib32","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1161\/CIRCULATIONAHA.118.036823","article-title":"In Aptamers They Trust: Caveats of the SOMAscan Biomarker Discovery Platform From SomaLogic","volume":"138","author":"Joshi","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.arr.2026.103058_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10989-023-10570-x","article-title":"Dried Blood Spot Sampling in Protein and Peptide Bioanalysis: Optimism, Experience, and the Path Forward","volume":"29","author":"Kaareddy","year":"2023","journal-title":"Int J. Pept. Res Ther."},{"key":"10.1016\/j.arr.2026.103058_bib34","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3233\/JAD-230419","article-title":"Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer\u2019s Disease or Other Neurological Diseases","volume":"96","author":"Kawarabayashi","year":"2023","journal-title":"JAD"},{"key":"10.1016\/j.arr.2026.103058_bib35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2026.103058_bib36","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.3390\/ijms23116079","article-title":"Neuroimaging Modalities in Alzheimer\u2019s Disease: Diagnosis and Clinical Features","volume":"23","author":"Kim","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.arr.2026.103058_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac155","article-title":"Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment","volume":"4","author":"Kivis\u00e4kk","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.arr.2026.103058_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116561","article-title":"GC-MS uncovers unique metabolic markers of drug-resistant epilepsy in capillary but not venous dried blood spots","volume":"253","author":"Kong","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.arr.2026.103058_bib39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/jnc.15465","article-title":"Mass spectrometry-based methods for robust measurement of Alzheimer\u2019s disease biomarkers in biological fluids","volume":"159","author":"Korecka","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2026.103058_bib40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.14283\/jpad.2023.61","article-title":"Burden of illness in people with alzheimer\u2019s disease: a systematic review of epidemiology, comorbidities and mortality","volume":"11","author":"Lanct\u00f4t","year":"2024","journal-title":"J. Prev. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2026.103058_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae396","article-title":"Glial fibrillary acidic protein in Alzheimer\u2019s disease: a narrative review","volume":"6","author":"Leipp","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.arr.2026.103058_bib42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40120-019-00164-5","article-title":"An Update on Blood-Based Markers of Alzheimer\u2019s Disease Using the SiMoA Platform","volume":"8","author":"Li","year":"2019","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.arr.2026.103058_bib43","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1021\/acs.analchem.8b03636","article-title":"Paper Microfluidics for Point-of-Care Blood-Based Analysis and Diagnostics","volume":"91","author":"Li","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.arr.2026.103058_bib44","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1042\/ETLS20210249","article-title":"Applied machine learning in Alzheimer\u2019s disease research: omics, imaging, and clinical data","volume":"5","author":"Li","year":"2021","journal-title":"Emerg. Top. Life Sci."},{"key":"10.1016\/j.arr.2026.103058_bib45","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3233\/JAD-200475","article-title":"Plasma Amyloid-\u03b2 Biomarker Associated with Cognitive Decline in Preclinical Alzheimer\u2019s Disease","volume":"77","author":"Lim","year":"2020","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2026.103058_bib46","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/acn3.726","article-title":"A metabolomic approach to identifying biomarkers in blood of Alzheimer\u2019s disease","volume":"6","author":"Lin","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2026.103058_bib47","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41398-021-01362-2","article-title":"Plasma lipidome is dysregulated in Alzheimer\u2019s disease and is associated with disease risk genes","volume":"11","author":"Liu","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2026.103058_bib48","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/s41591-025-03494-0","article-title":"Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia","volume":"31","author":"Llibre-Guerra","year":"2025","journal-title":"Nat. Med"},{"key":"10.1016\/j.arr.2026.103058_bib49","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2427178","article-title":"Association between serum neurofilament light chain levels and chronic kidney disease: a cross-sectional population-based study from the National Health and Nutrition Examination Survey (2013\u20132014 cycle)","volume":"46","author":"Lu","year":"2024","journal-title":"Ren. Fail."},{"key":"10.1016\/j.arr.2026.103058_bib50","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1021\/acschemneuro.3c00641","article-title":"Blood Biomarkers in Alzheimer\u2019s Disease","volume":"14","author":"Mandal","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2026.103058_bib51","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.14283\/jpad.2024.110","article-title":"Performance of Plasma Biomarkers Combined with Structural MRI to Identify Candidate Participants for Alzheimer\u2019s Disease-Modifying Therapy","volume":"11","author":"Manjavong","year":"2024","journal-title":"J. Prev. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2026.103058_bib52","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jalz.2011.05.2243","article-title":"The Alzheimer\u2019s Association external quality control program for cerebrospinal fluid biomarkers","volume":"7","author":"Mattsson","year":"2011","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.arr.2026.103058_bib53","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103058_bib54","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.1038\/s41467-020-19957-6","article-title":"Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies","volume":"11","author":"Mattsson-Carlgren","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103058_bib55","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jamaneurol.2022.5272","article-title":"Prediction of longitudinal cognitive decline in preclinical Alzheimer disease using plasma biomarkers","volume":"80","author":"Mattsson-Carlgren","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103058_bib56","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16089","article-title":"Plasma neurofilament light chain predicts Alzheimer\u2019s disease in patients with subjective cognitive decline and mild cognitive impairment: a cross-sectional and longitudinal study","volume":"31","author":"Mazzeo","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2026.103058_bib57","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103058_bib58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40120-022-00428-7","article-title":"The early diagnosis of alzheimer\u2019s disease: a patient-centred conversation with the care team","volume":"12","author":"Nasreddine","year":"2023","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.arr.2026.103058_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2025.123562","article-title":"Neurofilament light chain and Alzheimer pathology biomarkers in elderly people with multiple sclerosis","volume":"475","author":"Novarella","year":"2025","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2026.103058_bib60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40120-019-00165-4","article-title":"A Review on MS-based blood biomarkers for Alzheimer\u2019s Disease","volume":"8","author":"Oeckl","year":"2019","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.arr.2026.103058_bib61","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.1038\/s41598-024-56837-1","article-title":"Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer\u2019s Disease Neuroimaging Initiative cohort","volume":"14","author":"Oka","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2026.103058_bib62","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11011-022-01114-1","article-title":"Blood-based biomarkers in Alzheimer\u2019s disease: a mini-review","volume":"38","author":"Padala","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.arr.2026.103058_bib63","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/ADR-230029","article-title":"Plasma Biomarkers of Alzheimer\u2019s Disease: A Review of Available Assays, Recent Developments, and Implications for Clinical Practice","volume":"7","author":"Pais","year":"2023","journal-title":"J. Alzheimer\u2019S. Dis. Rep."},{"key":"10.1016\/j.arr.2026.103058_bib64","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911170","article-title":"Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer\u2019s disease","volume":"11","author":"Palmqvist","year":"2019","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.arr.2026.103058_bib65","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.arr.2026.103058_bib66","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41591-021-01348-z","article-title":"Prediction of future Alzheimer\u2019s disease dementia using plasma phospho-tau combined with other accessible measures","volume":"27","author":"Palmqvist","year":"2021","journal-title":"Nat. Med"},{"key":"10.1016\/j.arr.2026.103058_bib67","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.2024.13855","article-title":"Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care","volume":"332","author":"Palmqvist","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.arr.2026.103058_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-025-03622-w","article-title":"Plasma phospho-tau217 for Alzheimer\u2019s disease diagnosis in primary and secondary care using a fully automated platform","author":"Palmqvist","year":"2025","journal-title":"Nat. Med"},{"issue":"1","key":"10.1016\/j.arr.2026.103058_bib69","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-024-01655-w","article-title":"Plasma phospho-tau217 as a predictive biomarker for Alzheimer\u2019s disease in a large south American cohort","volume":"17","author":"Pandey","year":"2025","journal-title":"Alz Res Ther."},{"key":"10.1016\/j.arr.2026.103058_bib70","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/brain\/awy347","article-title":"Plasma tau\/amyloid-\u03b21\u201342 ratio predicts brain tau deposition and neurodegeneration in Alzheimer\u2019s disease","volume":"142","author":"Park","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103058_bib71","doi-asserted-by":"crossref","first-page":"6822","DOI":"10.1038\/s41467-021-27164-0","article-title":"Synergistic insights into human health from aptamer- and antibody-based proteomic profiling","volume":"12","author":"Pietzner","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103058_bib72","doi-asserted-by":"crossref","unstructured":"Puerta, R., Cano, A., Garc\u00eda-Gonz\u00e1lez, P., Garc\u00eda-Guti\u00e9rrez, F., Capdevila, M., De Rojas, I., Oliv\u00e9, C., Bl\u00e1zquez-Folch, J., Sotolongo-Grau, O., Miguel, A., Montrreal, L., Martino-Adami, P., Khan, A., Orellana, A., Sung, Y.J., Frikke-Schmidt, R., Marchant, N., Lambert, J.C., Rosende-Roca, M., Alegret, M., Fern\u00e1ndez, M.V., Marqui\u00e9, M., Valero, S., T\u00e1rraga, L., Cruchaga, C., Ram\u00edrez, A., Boada, M., Smets, B., Cabrera-Socorro, A., Ruiz, A., 2024. Head-to-head comparison of aptamer- and antibody-based proteomic platforms in human cerebrospinal fluid samples from a real-world memory clinic cohort. \u3008https:\/\/doi.org\/10.1101\/2024.07.18.24310563\u3009.","DOI":"10.1101\/2024.07.18.24310563"},{"key":"10.1016\/j.arr.2026.103058_bib73","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s10571-023-01330-y","article-title":"Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer\u2019s Disease","volume":"43","author":"Rani","year":"2023","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.arr.2026.103058_bib74","doi-asserted-by":"crossref","DOI":"10.2196\/67437","article-title":"Using machine learning to predict cognitive decline in older adults from the Chinese longitudinal healthy longevity survey: Model development and validation study","volume":"8","author":"Ren","year":"2025","journal-title":"JMIR Aging"},{"key":"10.1016\/j.arr.2026.103058_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanhl.2024.07.013","article-title":"Challenges in the practical implementation of blood biomarkers for Alzheimer\u2019s disease","volume":"5","author":"Sch\u00f6ll","year":"2024","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.arr.2026.103058_bib76","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1093\/brain\/awac138","article-title":"Hippocampal-subfield microstructures and their relation to plasma biomarkers in Alzheimer\u2019s disease","volume":"145","author":"Shahid","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103058_bib77","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jalz.2019.06.4951","article-title":"Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay","volume":"15","author":"Shi","year":"2019","journal-title":"Alzheimer\u2019S. amp Dement."},{"key":"10.1016\/j.arr.2026.103058_bib78","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer\u2019s amyloid-\u03b21-40 peptide from brain by LDL receptor\u2013related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.arr.2026.103058_bib79","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/alz.12283","article-title":"The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer\u2019s disease","volume":"17","author":"Simr\u00e9n","year":"2021","journal-title":"Alzheimer\u2019S. amp Dement."},{"key":"10.1016\/j.arr.2026.103058_bib80","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2217\/bmm-2021-0219","article-title":"Ultrasensitive detection of blood biomarkers of Alzheimer\u2019S and Parkinson\u2019s diseases: a systematic review","volume":"15","author":"Singh","year":"2021","journal-title":"Biomark. Med."},{"key":"10.1016\/j.arr.2026.103058_bib81","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/ene.14704","article-title":"Head-to-head comparison of amplified plasmonic exosome A\u03b242 platform and single-molecule array immunoassay in a memory clinic cohort","volume":"28","author":"Tanaka","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2026.103058_bib82","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain\u2014implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2026.103058_bib83","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2026.103058_bib84","article-title":"Plasma p-tau immunoassays in clinical research for Alzheimer\u2019s disease","volume":"21","author":"Teunissen","year":"2025","journal-title":"Alzheimer\u2019S. amp Dement."},{"key":"10.1016\/j.arr.2026.103058_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14442","article-title":"Plasma A\u03b242 \/A\u03b240 is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer\u2019s disease spectrum","author":"Trelle","year":"2025","journal-title":"Alzheimer\u2019S. amp Dement. 21"},{"key":"10.1016\/j.arr.2026.103058_bib86","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1038\/s41598-023-29704-8","article-title":"Neurofilament-light chain quantification by Simoa and Ella in plasma from patients with dementia: a comparative study","volume":"13","author":"Truffi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2026.103058_bib87","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3390\/biom12081099","article-title":"Plasma P-Tau181 for the discrimination of alzheimer\u2019s disease from other primary dementing and\/or movement disorders","volume":"12","author":"Tzartos","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2026.103058_bib88","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fneur.2017.00310","article-title":"Multicenter analytical validation of A\u03b240 Immunoassays","volume":"8","author":"Van Waalwijk Van Doorn","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2026.103058_bib89","article-title":"Re-evaluation of the efficacy and safety of anti-A\u03b2 monoclonal antibodies (lecanemab\/donanemab) in the treatment of early Alzheimer\u2019s disease","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharm."},{"key":"10.1016\/j.arr.2026.103058_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102507","article-title":"Neuroimaging and biofluid biomarkers across race and ethnicity in older adults across the spectrum of cognition","volume":"101","author":"Wang","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103058_bib91","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40364-023-00485-6","article-title":"A blood-based composite panel that screens Alzheimer\u2019s disease","volume":"11","author":"Wang","year":"2023","journal-title":"Biomark. Res"},{"key":"10.1016\/j.arr.2026.103058_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1364658","article-title":"Clinical utility of plasma A\u03b242\/40 ratio by LC-MS\/MS in Alzheimer\u2019s disease assessment","volume":"15","author":"Weber","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2026.103058_bib93","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/14789450.2023.2255752","article-title":"Next-generation proteomics technologies in Alzheimer\u2019s disease: from clinical research to routine diagnostics","volume":"20","author":"Weiner","year":"2023","journal-title":"Expert Rev. Proteom."},{"key":"10.1016\/j.arr.2026.103058_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2018.06.1427","article-title":"In vivo stable isotope labeling and quantitative mass spectrometry of A\u03b2 plaque deposition and tauopathy in human AD brain","volume":"14","author":"Wildburger","year":"2018","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.arr.2026.103058_bib95","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1002\/alz.13390","article-title":"Artificial intelligence for biomarker discovery in Alzheimer\u2019s disease and dementia","volume":"19","author":"Winchester","year":"2023","journal-title":"Alzheimer\u2019S. amp Dement."},{"key":"10.1016\/j.arr.2026.103058_bib96","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-220673","article-title":"A review of application of A\u03b242\/40 ratio in diagnosis and Prognosis of Alzheimer\u2019s Disease","volume":"90","author":"Xu","year":"2022","journal-title":"JAD"},{"key":"10.1016\/j.arr.2026.103058_bib97","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s13318-023-00846-4","article-title":"Dried blood spots\u2014a platform for therapeutic drug monitoring (TDM) and Drug\/Disease Response Monitoring (DRM)","volume":"48","author":"Zailani","year":"2023","journal-title":"Eur. J. Drug Metab. Pharm."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726000504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726000504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:25:35Z","timestamp":1772853935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163726000504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":97,"alternative-id":["S1568163726000504"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2026.103058","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood-based biomarkers for Alzheimer's disease: Advances in early detection and monitoring of age-related neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2026.103058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103058"}}